global Point Of Care
Webinars
Emergence of Dengue Virus Beyond Endemic Areas: Evolving Trends and Diagnostics
Published June 16, 2025
Summary
The last few years have seen an emergence of dengue virus infection in parts of the developed world that previously had low incidence of the disease. This webinar will examine recent outbreaks in Europe, focusing on evolving risk trends. The discussion will also include the role of diagnostics in clinical case management and surveillance in non-traditional settings.
Learning Objectives
- Explain the recent outbreaks of dengue virus infection in the developed world, specifically Europe.
- Examine the risk factors for the recent outbreaks.
- Understand the different serological markers and how they aid in diagnosis.
Presenter Biography
Miguel J. Martinez, M.D., Ph.D,
Associate Professor
Clinical Director
Biomedical Diagnostic Center
Head of Virology
Microbiology Dept, CDB
Hospital Clínic- ISGlobal- University of Barcelona
Barcelona, Spain
Dr. Miguel J. Martinez obtained his degree in Medicine from the University of Navarra in 1999. He completed his specialization in Microbiology and Parasitology at Hospital Clínic de Barcelona in 2004. From 2005 to 2009, he worked at the Institut National de la Santé et de la Recherche Médicale (INSERM) in Lyon, France, where he earned his PhD studying the molecular mechanisms of Ebolavirus transcription and replication. He then returned to the Virology Section of the Microbiology Department at Hospital Clínic de Barcelona, where he currently serves as Head of Virology. He is also an Associate Researcher at the Barcelona Institute for Global Health (ISGlobal) and an Associate Professor of Medicine at the University of Barcelona. In January 2025, he was appointed Clinical Director of the Biomedical Diagnostic Center at Hospital Clínic de Barcelona, overseeing the laboratories of Immunology, Biochemistry, Pathology, Microbiology, and Molecular Biology. His main areas of expertise and research include emerging viruses—particularly arboviruses—and infectious causes of death in low- and middle-income countries.
Who Should Watch
Physicians, Point-of-Care Coordinators,
In-Training Individuals, Nurses, and Other HCPs